Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gold Country Seed was a regional agricultural biotechnology company specializing in the development and distribution of high-performing corn and soybean seeds for the Upper Midwest. Founded in 1987 and headquartered in Hutchinson, Minnesota, the company focused on providing localized agronomic solutions and genetics tailored to the specific environmental conditions of the Northern Plains. In 2006, it was acquired by Monsanto as part of the American Seeds, Inc. (ASI) platform, and it subsequently became part of Bayer's Crop Science division following the 2018 merger. The brand was known for its 'Farmer-to-Farmer' approach and its utilization of advanced traits such as Roundup Ready and SmartStax technologies. In 2020, Bayer announced the consolidation of Gold Country Seed into its national Channel seed brand to streamline its regional business operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gold Country Seed.